SEARCH

SEARCH BY CITATION

REFERENCES

  • Bos, J.L., Fearon, E.R., Hamilton, S.R., Verlaan-De Vries, M., Van Boom, J.H., Van Der Eb, A.J. and Vogelstein, B., Prevalence of ras gene mutations in human colorectal cancers. Nature (Lond.), 327, 293-297 (1987).
  • Capellá, G., Cronauer-Mitra, S., Peinado, M.A. and Perucho, M., Frequency and spectrum of mutations at codons 12 and 13 of the K-ras gene in human tumors. Environ. Health Perspect., 93, 125-131 (1991).
  • Capellá, G., Lluis, F., Sancho, F. and Perucho, M., Activation of the c-K-ras gene in the colon adenoma-carcinoma sequence. Surg. Forum, 41, 459-461 (1990).
  • Forrester, K., Almoguera, C., Han, K., Grizzle, W.E. and Perucho, M., Detection of high incidence of K-ras during human colon tumorigenesis. Nature (Lond.), 327, 298-303 (1987).
  • Jiang, W., Khan, S.M., Guillem, J.G., Lu, S-H. and Weinstein, I.B., Rapid detection of ras oncogenes in human tumors: applications to colon, esophageal, and gastric cancer. Oncogene, 4, 923-928 (1989).
  • Khan, S.M., Jiang, W., Culbertson, T.A., Weinstein, I.B., Williams, G.M., Tomita, N. and Ronai, Z., Rapid and sensitive nonradioactive detection of mutant K-ras genes via enriched PCR amplification. Oncogene, 6, 1079-1083 (1991).
  • Kondo, H., Sugano, K., Fukayama, N., Kyogoku, A., Nose, H., Shimada, K., Ohkura, A., Ohtsu, A., Yoshida, S. and Shimosato, Y., Detection of point mutations in the K-ras oncogene at codon 12 in pure pancreatic juice for diagnosis of pancreatic carcinoma. Cancer, 73, 1589-1594 (1994).
  • Levi, S., Urbano-Ispizua, A., Gill, R., Thomas, D.M., Gilbertson, J., Foster, C. and Marshall, C.J., Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique. Cancer Res., 51, 3497-3502 (1991).
  • Mora, J., Puig, P., Boadas, J., Urgell, E., Montserrat, E., Lerma, E., González-Sastre, F., Lluís, F., Farré, A. and Capellá, G., K-ras gene mutations in the diagnosis of fine-needle aspirates of pancreatic masses: prospective study using two techniques with different detection limits. Clin. Chem., 44, 2243-2248 (1998).
  • Nedergaard, T., Guldberg, P., Ralfkiaer, E. and Zeuthen, J., A one-step DGGE scanning method for detection of mutations in the K-, N-, and H-ras oncogenes: mutations at codons 12,13 and 61 are rare in B-cell non-hodgkin's lymphoma. Int J. Cancer, 71, 364-369 (1997).
  • Nollau, P., Moser, C., Weinland, G. and Wagener, C., Detection of K-ras mutations in stools of patients with colorectal cancer by mutant-enriched PCR. Int J. Cancer, 66, 332-336 (1996).
  • Orita, M., Suzuki, Y., Sekiya, T. and Hayashi, K., Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics, 5, 874-879 (1989).
  • Puig, P., Urgell, E., Capellá, G., Villanueva, A., Grau, M., Sancho, F.J., Pujol, J., Lluís, F., González-Sastre, F. and Mora, J., Improved detection of K-ras codon 12 mutations in fecal exfoliated cells. Lab. Invest., 79, 617-618 (1999).
  • Ratto, C., Flamini, G., Sofo, L., Nucera, P., Ippoliti, M., Curigliano, G., Ferretti, G., Sgambato, A., Merico, M., DogliettO, G.B., Cittadini, A. and Crucitti, F., Detection of oncogene mutation from neoplastic colonic cells exfoliated in feces. Dis. Colon Rectum, 39, 1238-1244 (1996).
  • Sidransky, D., Tokino, T., Hamilton, S.R., Kinzler, K.W., Levin, B., Frost, P. and Vogelstein, B., Identification of ras oncogene mutation in the stool of patients with curable colorectal tumors. Science, 256, 102-105 (1992).
  • Smith-Ravin, J., England, J., Talbot, I.C. and Bodmer, W., Detection of c-Ki-ras mutations in faecal samples from sporadic colorectal cancer patients. Gut, 36, 81-86 (1995).
  • Tada, M., Omata, M., Kawai, S., Saisho, H., Ohto, M., Saiki, R.K. and Sninsky, J.J., Detection of K-ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma. Cancer Res., 53, 2472-2474 (1993).
  • Tobi, M., Luo, F. and Ronai, Z., Detection of K-ras mutations in colonic effluent samples from patients without evidence of colorectal carcinoma. J. nat. Cancer Inst., 86, 1007-1010 (1994).
  • Villa, E., Dugani, A., Rebecchi, A.M., Vignoli, A., Grottola, A., Buttafoco, P., Losi, L., Perini, M., Trande, P., Merighi, A., Lerose, R. and Manenti, F., Identification of subjects at risk for colorectal carcinoma through a test based on K-ras determination in the stool. Gastroenterology, 110, 1346-1353 (1996).
  • Villanueva, A., Reyes, G., Cuatrecasas, M., Martínez, A., Erill, N., Lerma, E., Farré, A., Lluís, F. and Capellá, G., Diagnostic utility of K-ras mutations in fine-needle aspirates of pancreatic masses. Gastroenterology, 110, 1587-1594 (1996).
  • Ward, R., Hawkins, N., O'Grady, R., Sheehan, C., O'Connor, T., Impey, H., Roberts, N., Fuery, C. and Todd, A., Restriction endonuclease-mediated selective polymerase chain reaction. A novel assay for the detection of K-ras mutations in clinical samples. Amer. J. Pathol., 153, 373-379 (1998).
  • Winawer, S.J. and 19 others, Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology, 112, 594-642 (1997).